OncoZenge AB (publ) (STO:ONCOZ)
Sweden · Delayed Price · Currency is SEK 3.400
-0.100 (-2.86%)
Sep 24, 2026, 4:48 PM CET
OncoZenge AB Market Cap
OncoZenge AB has a market cap or net worth of 51.87 million as of September 24, 2026. Its market cap has decreased by -32.87% in one year.
Market Cap
51.87M
Enterprise Value
58.62M
Revenue
5.97M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.40
ChartMarket Cap Chart
Since February 12, 2021, OncoZenge AB's market cap has decreased from 89.02M to 51.87M, a decrease of -41.73%. That is a compound annual growth rate of -9.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 51.87M | -39.33% |
| Dec 30, 2025 | 85.49M | 94.64% |
| Dec 30, 2024 | 43.92M | 21.36% |
| Dec 29, 2023 | 36.19M | -43.82% |
| Dec 30, 2022 | 64.42M | -52.42% |
| Dec 30, 2021 | 135.41M | 52.11% |
| Feb 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biovica International AB | 90.20M |
| Alzinova AB | 86.43M |
| Ascelia Pharma AB | 82.79M |
| Spago Nanomedical AB | 75.85M |
| Pila Pharma AB | 75.15M |
| Annexin Pharmaceuticals AB | 69.89M |
| AcouSort AB | 63.07M |
| Modus Therapeutics Holding AB | 58.29M |